75 related articles for article (PubMed ID: 2763749)
1. [The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
Carol W; Jäger R; Martin P; Möller U
Zentralbl Gynakol; 1989; 111(12):793-9. PubMed ID: 2763749
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
[TBL] [Abstract][Full Text] [Related]
3. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
[TBL] [Abstract][Full Text] [Related]
4. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of contraceptive steroids with reference to long-term administration].
Carol W; Klinger G; Michels W; Boer J; Pocha C
Zentralbl Gynakol; 1991; 113(23):1298-303. PubMed ID: 1796663
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium.
Kreitmann B; Bugat R; Bayard F
J Clin Endocrinol Metab; 1979 Dec; 49(6):926-9. PubMed ID: 92478
[TBL] [Abstract][Full Text] [Related]
7. Oral contraception, 1986. Focus on Triphasil.
Ellsworth H
J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
[TBL] [Abstract][Full Text] [Related]
8. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
9. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
[TBL] [Abstract][Full Text] [Related]
10. [Studies on estradiol occupied and unoccupied receptors in human endometrial cytosol and nucleus: steroid receptors throughout the menstrual cycle and in cases of oral contraceptives administration (author's transl)].
Azumaguchi A; Tanaka S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):951-60. PubMed ID: 7304137
[TBL] [Abstract][Full Text] [Related]
11. [Endometrial interference of synthetic estrogens in fertility regulation.Is it necessary to interfere with the antiovulatory mechanism at the central nervous system level in order to obtain contraception?].
Sojo Aranda QI; Rojas T; Cortés-Gallegos V
Ginecol Obstet Mex; 1997 Oct; 65():449-51. PubMed ID: 9432479
[TBL] [Abstract][Full Text] [Related]
12. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Endrikat J; Parke S; Trummer D; Schmidt W; Duijkers I; Klipping C
Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of emergency contraception with gestrinone: a preliminary investigation.
Gao X; Wu E; Chen G
Contraception; 2007 Sep; 76(3):221-7. PubMed ID: 17707720
[TBL] [Abstract][Full Text] [Related]
14. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
15. [Rationale for prescribing oral contraceptives].
Teichmann AT
Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
[TBL] [Abstract][Full Text] [Related]
16. Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen.
Anderson FD; Hait H; Hsiu J; Thompson-Graves AL; Wilborn WH; Williams RF
Contraception; 2005 Jan; 71(1):55-9. PubMed ID: 15639074
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
[TBL] [Abstract][Full Text] [Related]
18. [Menstrual cycle stimulation in the in vitro fertilization program--effects on estrogen and progesterone receptors of the endometrium].
Seliger E; Schöneich C; Kaltwasser P; Bergleiter R; Buchmann J; Rothe K
Zentralbl Gynakol; 1988; 110(23):1499-506. PubMed ID: 3149099
[TBL] [Abstract][Full Text] [Related]
19. Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion.
Schleussner E; Brueckner T; Brautigam J; Michels W
Gynecol Endocrinol; 2001 Aug; 15(4):259-64. PubMed ID: 11560098
[TBL] [Abstract][Full Text] [Related]
20. [Estrogen and progesterone receptors in uterine cervix].
Brentani MM; Lopes MT; Pereyra EG; Pacheco MM; Oshima CT; Widman A; De Almeida PC
J Bras Ginecol; 1985; 95(9):411-5. PubMed ID: 12267713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
